Adaptive Biotechnologies Corp (NASDAQ: ADPT) is 67.31% higher on its value in year-to-date trading and has touched a low of $2.95 and a high of $10.28 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ADPT stock was last observed hovering at around $9.84 in the last trading session, with the day’s gains setting it 0.19%.
Currently trading at $10.03, the stock is 27.95% and 28.07% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.71 million and changing 1.93% at the moment leaves the stock 62.47% off its SMA200. ADPT registered 259.50% gain for a year compared to 6-month gain of 98.22%.
The stock witnessed a 35.36% loss in the last 1 month and extending the period to 3 months gives it a 30.26%, and is 29.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.71% over the week and 9.23% over the month.
Adaptive Biotechnologies Corp (ADPT) has around 619 employees, a market worth around $1.52B and $189.53M in sales. Profit margin for the company is -74.84%. Distance from 52-week low is 240.00% and -2.43% from its 52-week high. The company has generated returns on investments over the last 12 months (-35.60%).
The EPS is expected to grow by 21.47% this year.
Adaptive Biotechnologies Corp (ADPT) Top Institutional Holders
The shares outstanding are 151.92M, and float is at 141.74M with Short Float at 6.98%.
The top institutional shareholder in the company is VIKING GLOBAL INVESTORS LP with over 29.99 million shares valued at $108.58 million. The investor’s holdings represent 20.3466% of the ADPT Shares outstanding. As of 2024-06-30, the second largest holder is RUBRIC CAPITAL MANAGEMENT LP with 14.0 million shares valued at $50.68 million to account for 9.4971 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 11.66 million shares representing 7.9124% and valued at over $42.22 million, while MATRIX CAPITAL MANAGEMENT COMPANY, LP holds 7.8504 of the shares totaling 11.57 million with a market value of $41.89 million.
Adaptive Biotechnologies Corp (ADPT) Insider Activity
The most recent transaction is an insider sale by ROBINS HARLAN S, the company’s Chief Scientific Officer. SEC filings show that ROBINS HARLAN S sold 68,412 shares of the company’s common stock on May 01 ’25 at a price of $7.35 per share for a total of $0.5 million. Following the sale, the insider now owns 1.28 million shares.
Still, SEC filings show that on Mar 24 ’25, ROBINS HARLAN S (Chief Scientific Officer) disposed off 1,698 shares at an average price of $9.00 for $15282.0. The insider now directly holds 1,279,524 shares of Adaptive Biotechnologies Corp (ADPT).
